Industry
Biotechnology
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
June 13, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 13, 2024 | 4:09 pm
Portfolio Pulse from ryanfaloona@benzinga.com
June 13, 2024 | 12:28 pm
Portfolio Pulse from Benzinga Newsdesk
June 13, 2024 | 12:16 pm
Portfolio Pulse from Benzinga Insights
June 10, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 4:47 pm
Portfolio Pulse from Benzinga Insights
June 06, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 12:04 pm
Portfolio Pulse from Avi Kapoor
March 28, 2024 | 6:08 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.